Zacks Investment Research on MSN
Ataibeckley completes VLS-01 dosing in Phase IIb depression study
AtaiBeckley ATAI announced the completion of dosing the last patient in the phase IIb Elumina study evaluating VLS-01 for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results